NCT05680805View on ClinicalTrials.gov

Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 27, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Polycystic Ovary SyndromeMetformin
Interventions
DRUG

Metformin Hydrochloride

Metformin 1500 mg/day in 3 divided dose for 24 weeks

Trial Locations (1)

1000

Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka

All Listed Sponsors
collaborator

Department of Genetic Engineering and Biotechnology, Dhaka University

UNKNOWN

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER